MK

Matthew Kelley

Scientific Advisor at Decibel Therapeutics

Director of the Laboratory of Cochlear Development in the Intramural Program at the National Institute on Deafness and Other Communication Disorders, National Institutes of Health.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Decibel Therapeutics

Decibel Therapeutics, a clinical-stage biotechnology company, has established the world’s first comprehensive drug discovery, development, and translational research platform for hearing and balance disorders.


Industries

Employees

51-200

Links